Europe's problems will not sink the U.S. economy because the American recovery is self-sustaining and driven by domestic demand, said Jeff Greenberg, Senior Economist at J.P. Morgan Private Bank.
Geopolitical problems are raising emotions in the market, making it easier to identify short sale candidates, said Dr.
Smartphone shipments at BlackBerry grew 15% in the second quarter from the prior period.
MannKind signed a $925 million licensing pact with French drug maker Sanofi this week to sell its diabetes drug Afrezza.
Applied Materials posted third quarter earnings of 28 cents a share on revenue of $2.27 billion.
The high yield bonds being sold by retail investors in the past month are being scooped up by institutional buyers seeking deals.
Pfizer's stock may currently be out of favor, but the drug giant's fortunes will soon turn due to its strong cash flow and undervalued pipeline.
Verizon offers a safe harbor and an attractive dividend in a highly valued market beset with geopolitical problems, said Peter Tuz, portfolio manager for the Chase Growth Fund.
The addition of 1,900 homes to its portfolio and success on the leasing front is driving the revenue surge at Starwood Waypoint, said the company's Co-CEO Gary Beasley.
Facebook's growth in mobile advertising revenue makes the stock entirely worth its high valuation, said Michael Sansoterra, portfolio manager for the RidgeWorth Large Cap Growth Fund.